NCT03646799View on ClinicalTrials.gov

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 30, 2018

Primary Completion Date

September 9, 2018

Study Completion Date

September 14, 2018

Conditions
Type II Diabetes
Interventions
DRUG

CKD-387

test drug

DRUG

D484

reference drug

Trial Locations (1)

Unknown

RECRUITING

Yonsei University Severance Hospital, Soeul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY